Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$7.60 USD
-0.35 (-4.40%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $7.50 -0.10 (-1.32%) 7:48 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 25.00% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.80 |
Next Year | -1.43 |
EPS (TTM) | -1.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.52M | 7.70M | 27.16M | 40.65M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 7.81M | 7.81M | 27.55M | 54.00M |
Low Estimate | 7.23M | 7.59M | 26.76M | 27.30M |
Year ago Sales | 17.48M | 5.77M | 34.15M | 27.16M |
Year over Year Growth Est. | -56.98% | 33.45% | -20.49% | 49.70% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.40 | -1.80 | -1.43 |
# of Estimates | 3 | 2 | 3 | 4 |
Most Recent Consensus | -0.42 | -0.44 | -1.88 | -1.96 |
High Estimate | -0.35 | -0.35 | -1.70 | -1.08 |
Low Estimate | -0.42 | -0.44 | -1.88 | -1.96 |
Year ago EPS | -0.34 | -0.57 | -2.34 | -1.80 |
Year over Year Growth Est. | -11.76% | 29.82% | 23.08% | 20.51% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 3 | 3 |
Up Last 60 Days | 2 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.40 | -1.80 | -1.43 |
7 Days Ago | -0.38 | -0.40 | -1.80 | -1.43 |
30 Days Ago | -0.56 | -0.56 | -2.20 | -1.67 |
60 Days Ago | -0.56 | -0.56 | -2.20 | -1.67 |
90 Days Ago | -0.56 | -0.56 | -2.20 | -1.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.40 | -1.80 | -1.42 |
Zacks Consensus Estimate | -0.38 | -0.40 | -1.80 | -1.43 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.29% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.59 | -0.57 | -0.34 | NA |
Estimate | -0.60 | -0.55 | -0.79 | -0.72 | NA |
Difference | 0.15 | -0.04 | 0.22 | 0.38 | 0.18 |
Surprise | 25.00% | -7.27% | 27.85% | 52.78% | 24.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more